AAAAAA
Results: 1-25/66
Authors:
Tavtigian, SV
Simard, J
Teng, DHF
Abtin, V
Baumgard, M
Beck, A
Camp, NJ
Carillo, AR
Chen, Y
Dayananth, P
Desrochers, M
Dumont, M
Farnham, JM
Frank, D
Frye, C
Ghaffari, S
Gupte, JS
Hu, R
Iliev, D
Janecki, T
Kort, EN
Laity, KE
Leavitt, A
Leblanc, G
McArthur-Morrison, J
Pederson, A
Penn, B
Peterson, KT
Reid, JE
Richards, S
Schroeder, M
Smith, R
Snyder, SC
Swedlund, B
Swensen, J
Thomas, A
Tranchant, M
Woodland, AM
Labrie, F
Skolnick, MH
Neuhausen, S
Rommens, J
Cannon-Albright, LA
Citation: Sv. Tavtigian et al., A candidate prostate cancer susceptibility gene at chromosome 17p, NAT GENET, 27(2), 2001, pp. 172-180
Authors:
Pelletier, G
Labrie, C
Martel, C
Li, S
Labrie, F
Citation: G. Pelletier et al., Role of extra-ovarian oestrogens in the regulation of gonadotropin releasing hormone mRNA expression in the rat brain, J NEUROENDO, 13(8), 2001, pp. 678-682
Authors:
Pelletier, G
Luu-The, V
El-Alfy, M
Li, S
Labrie, F
Citation: G. Pelletier et al., Immunoelectron microscopic localization of 3 beta-hydroxysteroid dehydrogenase and type 5 17 beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland, J MOL ENDOC, 26(1), 2001, pp. 11-19
Authors:
Zhu, DW
Cantin, L
Nahoum, V
Rehse, P
Luu-The, V
Labrie, F
Breton, R
Lin, SX
Citation: Dw. Zhu et al., Crystallization and preliminary X-ray crystallographic analysis of the human type 3 3 alpha-hydroxysteroid dehydrogenase at 1.8 angstrom resolution, ACT CRYST D, 57, 2001, pp. 589-591
Authors:
Labrie, F
Russo, J
McLachlan, J
Bourguignon, JP
Leffers, H
Spearow, J
Fink-Gremmels, J
Schonfelder, G
Citation: F. Labrie et al., Carcinogenicity of estrogens in human breast epithelial cells - Discussion, APMIS, 109, 2001, pp. S109-S111
Authors:
Risbridger, G
von Saal, F
Labrie, F
Soto, A
Sharpe, R
Michna, H
Citation: G. Risbridger et al., Altered prostate growth and daily sperm production in male mice exposed prenatally to subclinical doses of 17 alpha-ethinyl oestradiol - Discussion, APMIS, 109, 2001, pp. S286-S288
Authors:
Pescovitz, O
Vollmer, G
Korach, K
Soto, A
Labrie, F
Leffers, H
Huff, J
Citation: O. Pescovitz et al., Phytoestrogens and carcinogenesis - differential effects of genistein in experimental models of normal and malignant rat endometrium - Discussion, APMIS, 109, 2001, pp. S517-S518
Authors:
Luu-The, V
Dufort, I
Pelletier, G
Labrie, F
Citation: V. Luu-the et al., Type 5 17 beta-hydroxysteroid dehydrogenase: its role in the formation of androgens in women, MOL C ENDOC, 171(1-2), 2001, pp. 77-82
Authors:
Sauve, FD
McBroom, LDB
Gallant, J
Moraitis, AN
Labrie, F
Giguere, V
Citation: Fd. Sauve et al., CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant, MOL CELL B, 21(1), 2001, pp. 343-353
Authors:
Labrie, F
Luu-The, V
Labrie, C
Simard, J
Citation: F. Labrie et al., DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology, FRONT NEURO, 22(3), 2001, pp. 185-212
Authors:
Labrie, F
Labrie, C
Belanger, A
Giguere, V
Simard, J
Merand, Y
Gauthier, S
Luu-The, V
Candas, B
Martel, C
Luo, SQ
Citation: F. Labrie et al., Pure selective estrogen receptor modulators, new molecules having absolutecell specificity ranging from pure antiestrogenic to complete estrogen-like activities, ADV PROTEIN, 56, 2001, pp. 293
Authors:
Barbier, O
Albert, C
Martineau, I
Vallee, M
High, K
Labrie, F
Hum, DW
Labrie, C
Belanger, A
Citation: O. Barbier et al., Glucuronidation of the nonsteroidal antiestrogen EM-652 (SCH 57068), by human and monkey steroid conjugating UDP-glucuronosyltransferase enzymes, MOLEC PHARM, 59(3), 2001, pp. 636-645
Authors:
Pelletier, G
Li, S
Luu-The, V
Tremblay, Y
Belange, A
Labrie, F
Citation: G. Pelletier et al., Immunoelectron microscopic localization of three key steroidogenic enzymes(cytochrome P450(scc), 3 beta-hydroxysteroid dehydrogenase and cytochrome P450(c17)) in rat adrenal cortex and gonads, J ENDOCR, 171(2), 2001, pp. 373-383
Authors:
Dufort, I
Labrie, F
Luu-The, V
Citation: I. Dufort et al., Human types 1 and 3 3 alpha-hydroxysteroid dehydrogenases: Differential lability and tissue distribution, J CLIN END, 86(2), 2001, pp. 841-846
Authors:
Nahoum, V
Gangloff, A
Legrand, P
Zhu, DW
Cantin, L
Zhorov, BS
Luu-The, V
Labrie, F
Breton, R
Lin, SX
Citation: V. Nahoum et al., Structure of the human 3 alpha-hydroxysteroid dehydrogenase type 3 in complex with testosterone and NADP at 1.25-A resolution, J BIOL CHEM, 276(45), 2001, pp. 42091-42098
Authors:
Labrie, F
Candas, B
Cusan, L
Gomez, JL
Citation: F. Labrie et al., The Laval University screening trial results, CURR CLIN U, 2001, pp. 255-279
Authors:
Labrie, F
Citation: F. Labrie, Screening and hormonal therapy of localized prostate cancer shows major benefits on survival, CANCER J, 6, 2000, pp. S182-S187
Authors:
Singh, R
Eeles, RA
Durocher, F
Simard, J
Edwards, S
Badzioch, M
Kote-Jarai, Z
Teare, D
Ford, D
Dearnaley, D
Ardern-Jones, A
Murkin, A
Dowe, A
Shearer, R
Kelly, J
Labrie, F
Easton, D
Narod, SA
Tonin, PN
Foulkes, WD
Citation: R. Singh et al., High risk genes predisposing to prostate cancer development - do they exist?, PROSTATE C, 3(4), 2000, pp. 241-247
Authors:
El-Alfy, M
Pelletier, G
Hermo, LS
Labrie, F
Citation: M. El-alfy et al., Unique features of the basal cells of human prostate epithelium, MICROSC RES, 51(5), 2000, pp. 436-446
Authors:
Labrie, F
Luu-The, V
Lin, SX
Simard, J
Labrie, C
Citation: F. Labrie et al., Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues, TRENDS ENDO, 11(10), 2000, pp. 421-427
Authors:
Martel, C
Picard, S
Richard, V
Belanger, A
Labrie, C
Labrie, F
Citation: C. Martel et al., Prevention of bone loss by EM-800 and raloxifene in the ovariectomized rat, J STEROID B, 74(1-2), 2000, pp. 45-56
Authors:
Labrie, F
Luu-The, V
Lin, SX
Simard, J
Labrie, C
El-Alfy, M
Pelletier, G
Belanger, A
Citation: F. Labrie et al., Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease, J MOL ENDOC, 25(1), 2000, pp. 1-16
Authors:
Singh, SM
Gauthier, S
Labrie, F
Citation: Sm. Singh et al., Androgen receptor antagonists (antiandrogens): Structure-activity relationships, CURR MED CH, 7(2), 2000, pp. 211-247
Authors:
Picard, F
Deshaies, Y
Lalonde, J
Samson, P
Labrie, C
Belanger, A
Labrie, F
Richard, D
Citation: F. Picard et al., Effects of the estrogen antagonist EM-652.HCl on energy balance and lipid metabolism in ovariectomized rats, INT J OBES, 24(7), 2000, pp. 830-840
Authors:
Mauriege, P
Langin, D
Montminy, V
Martel, C
Despres, JP
Belanger, A
Labrie, F
Deshaies, Y
Citation: P. Mauriege et al., Effect of a long-term percutaneous adrenal steroid treatment on rat adipose tissble metabolism, INT J OBES, 24, 2000, pp. S148-S150